Apply Now

HIV & Cannabis Research Study

Researchers at Yale University are looking for adult participants for a study evaluating the impact cannabis has on those diagnosed with HIV. Adults ages 18+ may qualify to participate in this study. Join our compensated study today!

See If I Qualify

Fast Facts

Diagnosed with HIV

Current use of cannabis within last 12 months OR past cannabis use within last 10 years

ages 18+

Compensation Provided

Conducted in New Haven, CT

Study Background

The purpose of this study is to learn more about how cannabis affects the immune system.

In this study, people with HIV (PWH) and people without HIV (PWoH) will be administered oral Dronabinol and blood will be drawn at three timepoints (pre-Dronabinol, 120 minutes and 360 minutes post-Dronabinol). This study will be conducted at Yale University sites (e.g., Clinical Neuroscience Research Unit (CNRU) at the Connecticut Mental Health Center (CMHC).

Advance research today and join our compensated study!

See If I Qualify

Additional Information

The goal of this study is to evaluate the impact of cannabis on adults diagnosed with HIV.

You may qualify for this study if you meet the following criteria.

Key Criteria:

  •  Adults 18+ diagnosed with HIV

  • Current use of cannabis within last 12 months OR past cannabis use within last 10 years

  • On antiretroviral therapy

  • No major or unstable medical conditions

  • No psychosis diagnosis

  • Have not donated blood within last 8 weeks

  • No sesame oil allergy

  • No history of seizures

All participants will undergo a preliminary phone screening evaluation, in-person screening visit, and test day visit. Following the test day visit, subjects will complete follow-up phone interviews at 24-hour, 1-month, 3 months, and 6 months post-test day visit.

Compensation is provided up to $200 for participation.

There is no cost for your child to participate in the study.
Tagged